Literature DB >> 10721682

Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.

S Kõks1, P T Männistö, M Bourin, J Shlik, V Vasar, E Vasar.   

Abstract

OBJECTIVE: To examine the influence of pre-experimental stress on the anxiogenic-like action of caerulein, an agonist of cholecystokinin (CCK) receptors. Differences in the anxiety levels of rats in summer and winter, and the role of CCK in these behavioural alterations, were also examined.
DESIGN: Prospective animal study.
INTERVENTIONS: Male Wistar rats were injected with the CCK agonist caerulein, or the CCK antagonists L-365,260 or devazepide, after being exposed to pre-experimental stress (handling and isolation). OUTCOME MEASURES: Performance in the plus-maze model of anxiety; serum levels of prolactin, thyrotropin and growth hormone; brain density and affinity of dopamine D2, serotonin 5-HT2 and CCK receptors.
RESULTS: Caerulein (5 micrograms/kg, subcutaneous injection) caused the strongest action in animals brought to the experimental room immediately before the experiment and kept in isolation after the administration of caerulein. Caerulein did not cause any reduction of exploratory activity in rats made familiar with the experimental room and kept in the home-cage after the injection of the CCK agonist. The anti-exploratory action of caerulein in stressed rats was reversed by the CCK antagonist L-365,260 (100 micrograms/kg, intraperitoneal injection), demonstrating the involvement of the CCKB receptor subtype. In addition, seasonal fluctuations occur in the exploratory activity of rats; such activity was much lower in July than in November. The rats displaying the reduced exploratory activity had an increased number of CCK receptors in the frontal cortex and hippocampus. Simultaneously, the density of serotonin 5-HT2 receptors in the frontal cortex, but not that of dopamine D2 receptors in the striatum, was elevated. The blood level of growth hormone was also higher in July.
CONCLUSIONS: The anti-exploratory action of caerulein appears to be dependent on the pre-experimental stress of rats. Moreover, the seasonal variations of exploratory behaviour of rats are evident in the plus-maze model of anxiety. The reduced exploratory activity in summer appears to be related to the elevated density of CCK and 5-HT2 receptors in the brain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10721682      PMCID: PMC1407703     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  43 in total

1.  Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers.

Authors:  D Koszycki; R M Zacharko; J M Le Mellédo; J Bradwejn
Journal:  Depress Anxiety       Date:  1998       Impact factor: 6.505

2.  Frequency of panic disorder in summer.

Authors:  O G Cameron
Journal:  Am J Psychiatry       Date:  1989-01       Impact factor: 18.112

3.  Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

Authors:  C de Montigny
Journal:  Arch Gen Psychiatry       Date:  1989-06

4.  Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour.

Authors:  S L Handley; S Mithani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-08       Impact factor: 3.000

Review 5.  Neurotransmitter regulation of anterior pituitary hormones.

Authors:  J Tuomisto; P Männistö
Journal:  Pharmacol Rev       Date:  1985-09       Impact factor: 25.468

6.  Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects.

Authors:  D S Charney; S W Woods; W K Goodman; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

Authors:  S Pellow; P Chopin; S E File; M Briley
Journal:  J Neurosci Methods       Date:  1985-08       Impact factor: 2.390

Review 8.  The role of corticotropin-releasing factor in depression and anxiety disorders.

Authors:  L Arborelius; M J Owens; P M Plotsky; C B Nemeroff
Journal:  J Endocrinol       Date:  1999-01       Impact factor: 4.286

9.  Behavioral differences in an elevated plus-maze: correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortex.

Authors:  L Rägo; R A Kiivet; J Harro; M Pŏld
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

10.  The behavioral effects of CCK8 injected into the medial nucleus accumbens are dependent on the motivational state of the rat.

Authors:  V Daugé; A Dor; J Féger; B P Roques
Journal:  Eur J Pharmacol       Date:  1989-04-12       Impact factor: 4.432

View more
  6 in total

1.  Opioid receptor-dependent sex differences in synaptic plasticity in the hippocampal mossy fiber pathway of the adult rat.

Authors:  Lauren C Harte-Hargrove; Ada Varga-Wesson; Aine M Duffy; Teresa A Milner; Helen E Scharfman
Journal:  J Neurosci       Date:  2015-01-28       Impact factor: 6.167

2.  Targeted invalidation of CCK2 receptor gene induces anxiolytic-like action in light-dark exploration, but not in fear conditioning test.

Authors:  Sirli Raud; Jürgen Innos; Urho Abramov; Ain Reimets; Sulev Kõks; Andres Soosaar; Toshimitsu Matsui; Eero Vasar
Journal:  Psychopharmacology (Berl)       Date:  2005-10-14       Impact factor: 4.530

3.  Elevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse.

Authors:  Qian Chen; Akira Nakajima; Corbin Meacham; Ya-Ping Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-28       Impact factor: 11.205

4.  Social instability in female rats: effects on anxiety and buspirone efficacy.

Authors:  József Haller; Johanna Baranyi; Nikoletta Bakos; József Halász
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

5.  Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat.

Authors:  Santiago J Ballaz; Michel Bourin; Huda Akil; Stanley J Watson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-09-14       Impact factor: 5.067

6.  Bi-directional effect of cholecystokinin receptor-2 overexpression on stress-triggered fear memory and anxiety in the mouse.

Authors:  Qian Chen; Mingxi Tang; Takayoshi Mamiya; Heh-In Im; Xiaoli Xiong; Anu Joseph; Ya-Ping Tang
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.